APO Research
Talk to an analyst

APO RESEARCH · REPORT

3 Phosphoinositide Dependent Protein Kinase 1

Compare research editions
View pricing & licenses

Selected research

Market Outlook & Growth Opportunities

Global 3 Phosphoinositide Dependent Protein Kinase 1 Market Outlook and Growth Opportunities 2026

19 December 2025192 pages

Choose your research edition.

Industry Research3 Phosphoinositide Dependent Protein Kinase 1 Industry Research Report 2026109 pages · $2,950 USDIndustry Growth & TrendsGlobal 3 Phosphoinositide Dependent Protein Kinase 1 Industry Growth and Trends Forecast to 203274 pages · $3,450 USDMarket StructureGlobal 3 Phosphoinositide Dependent Protein Kinase 1 Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032174 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal 3 Phosphoinositide Dependent Protein Kinase 1 Market Outlook and Growth Opportunities 2026192 pages · $4,250 USDMarket Analysis & ForecastGlobal 3 Phosphoinositide Dependent Protein Kinase 1 Market Analysis and Forecast 2026-2032192 pages · $4,950 USD

Market perspective

The global 3 Phosphoinositide Dependent Protein Kinase 1 market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a compound annual growth rate (CAGR) of % over 2026-2032.

The North America market for 3 Phosphoinositide Dependent Protein Kinase 1 is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The Europe market for 3 Phosphoinositide Dependent Protein Kinase 1 is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for 3 Phosphoinositide Dependent Protein Kinase 1 is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

In China, the 3 Phosphoinositide Dependent Protein Kinase 1 market is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Major global companies in the 3 Phosphoinositide Dependent Protein Kinase 1 market include Tolero Pharmaceuticals, Inc., Sunesis Pharmaceuticals, Inc. and Arno Therapeutics, Inc., among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

This report provides an overview of the global 3 Phosphoinositide Dependent Protein Kinase 1 market in terms of sales, revenue, and price, analyzing global market trends using historical revenue and sales data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.

The study covers key producers of 3 Phosphoinositide Dependent Protein Kinase 1 and sales in major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.

The report also presents 3 Phosphoinositide Dependent Protein Kinase 1 sales, revenue, market share, and industry ranking for the main manufacturers for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.

In addition, the report analyzes segment data by Type and Application—covering sales, revenue, and price—for 2021-2032, and evaluates and forecasts the 3 Phosphoinositide Dependent Protein Kinase 1 market size, projected growth trends, production technologies, key applications, and end-use industries.

3 Phosphoinositide Dependent Protein Kinase 1 Segment by Company

Tolero Pharmaceuticals, Inc.

Sunesis Pharmaceuticals, Inc.

Arno Therapeutics, Inc.

3 Phosphoinositide Dependent Protein Kinase 1 Segment by Type

SNS-229

PHT-427

HCI-1708

AR-12

Others

3 Phosphoinositide Dependent Protein Kinase 1 Segment by Application

Clinic

Hospital

Others

3 Phosphoinositide Dependent Protein Kinase 1 Segment by Region

North America

United States

Canada

Europe

Germany

France

U.K.

Italy

Netherlands

Asia-Pacific

China

Japan

South Korea

India

Australia

China Taiwan

Southeast Asia

South America

Mexico

Brazil

Argentina

Middle East & Africa

Turkey

Saudi Arabia

UAE

Study Objectives

1. To analyze and research the global 3 Phosphoinositide Dependent Protein Kinase 1 status and future forecast, involving, sales, revenue, growth rate (CAGR), market share, historical and forecast.

2. To present the key manufacturers, sales, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions 3 Phosphoinositide Dependent Protein Kinase 1 market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify 3 Phosphoinositide Dependent Protein Kinase 1 significant trends, drivers, influence factors in global and regions.

6. To analyze 3 Phosphoinositide Dependent Protein Kinase 1 competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global 3 Phosphoinositide Dependent Protein Kinase 1 market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of 3 Phosphoinositide Dependent Protein Kinase 1 and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in sales and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of 3 Phosphoinositide Dependent Protein Kinase 1.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Provides an overview of the 3 Phosphoinositide Dependent Protein Kinase 1 market, including product definition, global market growth prospects, sales value, sales volume, and average price forecasts (2021-2032).

Chapter 2: Analysis key trends, drivers, challenges, and opportunities within the global 3 Phosphoinositide Dependent Protein Kinase 1 industry.

Chapter 3: Detailed analysis of 3 Phosphoinositide Dependent Protein Kinase 1 manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.

Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: Sales and value of 3 Phosphoinositide Dependent Protein Kinase 1 in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of each country in the world.

Chapter 7: Sales and value of 3 Phosphoinositide Dependent Protein Kinase 1 in country level. It provides sigmate data by type, and by application for each country/region.

Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.

Chapter 10: Concluding Insights.

More report detail

Tables and figures
List of Tables Table 1. 3 Phosphoinositide Dependent Protein Kinase 1 Industry Trends Table 2. 3 Phosphoinositide Dependent Protein Kinase 1 Industry Drivers Table 3. 3 Phosphoinositide Dependent Protein Kinase 1 Industry Opportunities and Challenges Table 4. 3 Phosphoinositide Dependent Protein Kinase 1 Industry Restraints Table 5. Global 3 Phosphoinositide Dependent Protein Kinase 1 Revenue by Company (US$ Million) & (2021-2026) Table 6. Global 3 Phosphoinositide Dependent Protein Kinase 1 Revenue Share by Company (2021-2026) Table 7. Global 3 Phosphoinositide Dependent Protein Kinase 1 Sales Volume by Company (K Units) & (2021-2026) Table 8. Global 3 Phosphoinositide Dependent Protein Kinase 1 Sales Volume Share by Company (2021-2026) Table 9. Global 3 Phosphoinositide Dependent Protein Kinase 1 Average Price (US$/Unit) of Company (2021-2026) Table 10. Global 3 Phosphoinositide Dependent Protein Kinase 1 Company Ranking, (2024-2026) & (USD Million) Table 11. Global 3 Phosphoinositide Dependent Protein Kinase 1 Key Company Manufacturing Base & Headquarters Table 12. Global 3 Phosphoinositide Dependent Protein Kinase 1 Company, Product Type & Application Table 13. Global 3 Phosphoinositide Dependent Protein Kinase 1 Company Establishment Date Table 14. Global Company Market Concentration Ratio (CR5 and HHI) Table 15. Global 3 Phosphoinositide Dependent Protein Kinase 1 by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on Revenue of 2025) Table 16. Mergers & Acquisitions, Expansion Table 17. Significant Companies of SNS-229 Table 18. Significant Companies of PHT-427 Table 19. Significant Companies of HCI-1708 Table 20. Significant Companies of AR-12 Table 21. Significant Companies of Others Table 22. Global 3 Phosphoinositide Dependent Protein Kinase 1 Sales Volume by Type 2021 VS 2025 VS 2032 (K Units) Table 23. Global 3 Phosphoinositide Dependent Protein Kinase 1 Sales Volume by Type (2021-2026) & (K Units) Table 24. Global 3 Phosphoinositide Dependent Protein Kinase 1 Sales Volume by Type (2027-2032) & (K Units) Table 25. Global 3 Phosphoinositide Dependent Protein Kinase 1 Sales Volume Share by Type (2021-2026) Table 26. Global 3 Phosphoinositide Dependent Protein Kinase 1 Sales Volume Share by Type (2027-2032) Table 27. Global 3 Phosphoinositide Dependent Protein Kinase 1 Sales Value by Type 2021 VS 2025 VS 2032 (US$ Million) Table 28. Global 3 Phosphoinositide Dependent Protein Kinase 1 Sales Value by Type (2021-2026) & (US$ Million) Table 29. Global 3 Phosphoinositide Dependent Protein Kinase 1 Sales Value by Type (2027-2032) & (US$ Million) Table 30. Global 3 Phosphoinositide Dependent Protein Kinase 1 Sales Value Share by Type (2021-2026) Table 31. Global 3 Phosphoinositide Dependent Protein Kinase 1 Sales Value Share by Type (2027-2032) Table 32. Significant Companies of Clinic Table 33. Significant Companies of Hospital Table 34. Significant Companies of Others Table 35. Global 3 Phosphoinositide Dependent Protein Kinase 1 Sales Volume by Application 2021 VS 2025 VS 2032 (K Units) Table 36. Global 3 Phosphoinositide Dependent Protein Kinase 1 Sales Volume by Application (2021-2026) & (K Units) Table 37. Global 3 Phosphoinositide Dependent Protein Kinase 1 Sales Volume by Application (2027-2032) & (K Units) Table 38. Global 3 Phosphoinositide Dependent Protein Kinase 1 Sales Volume Share by Application (2021-2026) Table 39. Global 3 Phosphoinositide Dependent Protein Kinase 1 Sales Volume Share by Application (2027-2032) Table 40. Global 3 Phosphoinositide Dependent Protein Kinase 1 Sales Value by Application 2021 VS 2025 VS 2032 (US$ Million) Table 41. Global 3 Phosphoinositide Dependent Protein Kinase 1 Sales Value by Application (2021-2026) & (US$ Million) Table 42. Global 3 Phosphoinositide Dependent Protein Kinase 1 Sales Value by Application (2027-2032) & (US$ Million) Table 43. Global 3 Phosphoinositide Dependent Protein Kinase 1 Sales Value Share by Application (2021-2026) Table 44. Global 3 Phosphoinositide Dependent Protein Kinase 1 Sales Value Share by Application (2027-2032) Table 45. Global 3 Phosphoinositide Dependent Protein Kinase 1 Sales by Region: 2021 VS 2025 VS 2032 (K Units) Table 46. Global 3 Phosphoinositide Dependent Protein Kinase 1 Sales by Region (2021-2026) & (K Units) Table 47. Global 3 Phosphoinositide Dependent Protein Kinase 1 Sales Market Share by Region (2021-2026) Table 48. Global 3 Phosphoinositide Dependent Protein Kinase 1 Sales by Region (2027-2032) & (K Units) Table 49. Global 3 Phosphoinositide Dependent Protein Kinase 1 Sales Market Share by Region (2027-2032) Table 50. Global 3 Phosphoinositide Dependent Protein Kinase 1 Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 51. Global 3 Phosphoinositide Dependent Protein Kinase 1 Sales Value by Region (2021-2026) & (US$ Million) Table 52. Global 3 Phosphoinositide Dependent Protein Kinase 1 Sales Value Share by Region (2021-2026) Table 53. Global 3 Phosphoinositide Dependent Protein Kinase 1 Sales Value by Region (2027-2032) & (US$ Million) Table 54. Global 3 Phosphoinositide Dependent Protein Kinase 1 Sales Value Share by Region (2027-2032) Table 55. Global 3 Phosphoinositide Dependent Protein Kinase 1 Market Average Price (US$/Unit) by Region (2021-2026) Table 56. Global 3 Phosphoinositide Dependent Protein Kinase 1 Market Average Price (US$/Unit) by Region (2027-2032) Table 57. Global 3 Phosphoinositide Dependent Protein Kinase 1 Sales by Country: 2021 VS 2025 VS 2032 (K Units) Table 58. Global 3 Phosphoinositide Dependent Protein Kinase 1 Sales Value by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 59. Global 3 Phosphoinositide Dependent Protein Kinase 1 Sales by Country (2021-2026) & (K Units) Table 60. Global 3 Phosphoinositide Dependent Protein Kinase 1 Sales Market Share by Country (2021-2026) Table 61. Global 3 Phosphoinositide Dependent Protein Kinase 1 Sales by Country (2027-2032) & (K Units) Table 62. Global 3 Phosphoinositide Dependent Protein Kinase 1 Sales Market Share by Country (2027-2032) Table 63. Global 3 Phosphoinositide Dependent Protein Kinase 1 Sales Value by Country (2021-2026) & (US$ Million) Table 64. Global 3 Phosphoinositide Dependent Protein Kinase 1 Sales Value Market Share by Country (2021-2026) Table 65. Global 3 Phosphoinositide Dependent Protein Kinase 1 Sales Value by Country (2027-2032) & (US$ Million) Table 66. Global 3 Phosphoinositide Dependent Protein Kinase 1 Sales Value Market Share by Country (2027-2032) Table 67. Tolero Pharmaceuticals, Inc. Company Information Table 68. Tolero Pharmaceuticals, Inc. Business Overview Table 69. Tolero Pharmaceuticals, Inc. 3 Phosphoinositide Dependent Protein Kinase 1 Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 70. Tolero Pharmaceuticals, Inc. 3 Phosphoinositide Dependent Protein Kinase 1 Product Portfolio Table 71. Tolero Pharmaceuticals, Inc. Recent Development Table 72. Sunesis Pharmaceuticals, Inc. Company Information Table 73. Sunesis Pharmaceuticals, Inc. Business Overview Table 74. Sunesis Pharmaceuticals, Inc. 3 Phosphoinositide Dependent Protein Kinase 1 Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 75. Sunesis Pharmaceuticals, Inc. 3 Phosphoinositide Dependent Protein Kinase 1 Product Portfolio Table 76. Sunesis Pharmaceuticals, Inc. Recent Development Table 77. Arno Therapeutics, Inc. Company Information Table 78. Arno Therapeutics, Inc. Business Overview Table 79. Arno Therapeutics, Inc. 3 Phosphoinositide Dependent Protein Kinase 1 Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 80. Arno Therapeutics, Inc. 3 Phosphoinositide Dependent Protein Kinase 1 Product Portfolio Table 81. Arno Therapeutics, Inc. Recent Development Table 82. Key Raw Materials Table 83. Raw Materials Key Suppliers Table 84. 3 Phosphoinositide Dependent Protein Kinase 1 Distributors List Table 85. 3 Phosphoinositide Dependent Protein Kinase 1 Customers List Table 86. Research Programs/Design for This Report Table 87. Authors List of This Report Table 88. Secondary Sources Table 89. Primary Sources List of Figures Figure 1. 3 Phosphoinositide Dependent Protein Kinase 1 Product Image Figure 2. Global 3 Phosphoinositide Dependent Protein Kinase 1 Sales Value (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global 3 Phosphoinositide Dependent Protein Kinase 1 Sales Value (2021-2032) & (US$ Million) Figure 4. Global 3 Phosphoinositide Dependent Protein Kinase 1 Sales (2021-2032) & (K Units) Figure 5. Global 3 Phosphoinositide Dependent Protein Kinase 1 Sales Average Price (US$/Unit) & (2021-2032) Figure 6. Global 3 Phosphoinositide Dependent Protein Kinase 1 Company Revenue Ranking in 2025 (US$ Million) Figure 7. Global Top 5 and 10 Company Market Share by Revenue in 2025 (US$ Million) Figure 8. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 9. SNS-229 Image Figure 10. PHT-427 Image Figure 11. HCI-1708 Image Figure 12. AR-12 Image Figure 13. Others Image Figure 14. Global 3 Phosphoinositide Dependent Protein Kinase 1 Sales Volume by Type (2021 VS 2025 VS 2032) & (K Units) Figure 15. Global 3 Phosphoinositide Dependent Protein Kinase 1 Sales Volume Share 2021 VS 2025 VS 2032 Figure 16. Global 3 Phosphoinositide Dependent Protein Kinase 1 Sales Volume Share by Type (2021-2032) Figure 17. Global 3 Phosphoinositide Dependent Protein Kinase 1 Sales Value by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 18. Global 3 Phosphoinositide Dependent Protein Kinase 1 Sales Value Share 2021 VS 2025 VS 2032 Figure 19. Global 3 Phosphoinositide Dependent Protein Kinase 1 Sales Value Share by Type (2021-2032) Figure 20. Clinic Image Figure 21. Hospital Image Figure 22. Others Image Figure 23. Global 3 Phosphoinositide Dependent Protein Kinase 1 Sales Volume by Application (2021 VS 2025 VS 2032) & (K Units) Figure 24. Global 3 Phosphoinositide Dependent Protein Kinase 1 Sales Volume Share 2021 VS 2025 VS 2032 Figure 25. Global 3 Phosphoinositide Dependent Protein Kinase 1 Sales Volume Share by Application (2021-2032) Figure 26. Global 3 Phosphoinositide Dependent Protein Kinase 1 Sales Value by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 27. Global 3 Phosphoinositide Dependent Protein Kinase 1 Sales Value Share 2021 VS 2025 VS 2032 Figure 28. Global 3 Phosphoinositide Dependent Protein Kinase 1 Sales Value Share by Application (2021-2032) Figure 29. Global 3 Phosphoinositide Dependent Protein Kinase 1 Sales by Region: 2021 VS 2025 VS 2032 (K Units) Figure 30. Global 3 Phosphoinositide Dependent Protein Kinase 1 Sales Market Share by Region: 2021 VS 2025 VS 2032 Figure 31. Global 3 Phosphoinositide Dependent Protein Kinase 1 Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 32. Global 3 Phosphoinositide Dependent Protein Kinase 1 Sales Value Share by Region: 2021 VS 2025 VS 2032 Figure 33. North America 3 Phosphoinositide Dependent Protein Kinase 1 Sales Value (2021-2032) & (US$ Million) Figure 34. North America 3 Phosphoinositide Dependent Protein Kinase 1 Sales Value Share by Country (%), 2025 VS 2032 Figure 35. Europe 3 Phosphoinositide Dependent Protein Kinase 1 Sales Value (2021-2032) & (US$ Million) Figure 36. Europe 3 Phosphoinositide Dependent Protein Kinase 1 Sales Value Share by Country (%), 2025 VS 2032 Figure 37. Asia-Pacific 3 Phosphoinositide Dependent Protein Kinase 1 Sales Value (2021-2032) & (US$ Million) Figure 38. Asia-Pacific 3 Phosphoinositide Dependent Protein Kinase 1 Sales Value Share by Country (%), 2025 VS 2032 Figure 39. South America 3 Phosphoinositide Dependent Protein Kinase 1 Sales Value (2021-2032) & (US$ Million) Figure 40. South America 3 Phosphoinositide Dependent Protein Kinase 1 Sales Value Share by Country (%), 2025 VS 2032 Figure 41. Middle East & Africa 3 Phosphoinositide Dependent Protein Kinase 1 Sales Value (2021-2032) & (US$ Million) Figure 42. Middle East & Africa 3 Phosphoinositide Dependent Protein Kinase 1 Sales Value Share by Country (%), 2025 VS 2032 Figure 43. USA 3 Phosphoinositide Dependent Protein Kinase 1 Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 44. USA 3 Phosphoinositide Dependent Protein Kinase 1 Sales Value Share by Type, 2025 VS 2032 & (%) Figure 45. USA 3 Phosphoinositide Dependent Protein Kinase 1 Sales Value Share by Application, 2025 VS 2032 & (%) Figure 46. Canada 3 Phosphoinositide Dependent Protein Kinase 1 Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 47. Canada 3 Phosphoinositide Dependent Protein Kinase 1 Sales Value Share by Type, 2025 VS 2032 & (%) Figure 48. Canada 3 Phosphoinositide Dependent Protein Kinase 1 Sales Value Share by Application, 2025 VS 2032 & (%) Figure 49. Mexico 3 Phosphoinositide Dependent Protein Kinase 1 Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 50. Mexico 3 Phosphoinositide Dependent Protein Kinase 1 Sales Value Share by Type, 2025 VS 2032 & (%) Figure 51. Mexico 3 Phosphoinositide Dependent Protein Kinase 1 Sales Value Share by Application, 2025 VS 2032 & (%) Figure 52. Germany 3 Phosphoinositide Dependent Protein Kinase 1 Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 53. Germany 3 Phosphoinositide Dependent Protein Kinase 1 Sales Value Share by Type, 2025 VS 2032 & (%) Figure 54. Germany 3 Phosphoinositide Dependent Protein Kinase 1 Sales Value Share by Application, 2025 VS 2032 & (%) Figure 55. France 3 Phosphoinositide Dependent Protein Kinase 1 Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 56. France 3 Phosphoinositide Dependent Protein Kinase 1 Sales Value Share by Type, 2025 VS 2032 & (%) Figure 57. France 3 Phosphoinositide Dependent Protein Kinase 1 Sales Value Share by Application, 2025 VS 2032 & (%) Figure 58. U.K. 3 Phosphoinositide Dependent Protein Kinase 1 Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 59. U.K. 3 Phosphoinositide Dependent Protein Kinase 1 Sales Value Share by Type, 2025 VS 2032 & (%) Figure 60. U.K. 3 Phosphoinositide Dependent Protein Kinase 1 Sales Value Share by Application, 2025 VS 2032 & (%) Figure 61. Italy 3 Phosphoinositide Dependent Protein Kinase 1 Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 62. Italy 3 Phosphoinositide Dependent Protein Kinase 1 Sales Value Share by Type, 2025 VS 2032 & (%) Figure 63. Italy 3 Phosphoinositide Dependent Protein Kinase 1 Sales Value Share by Application, 2025 VS 2032 & (%) Figure 64. Spain 3 Phosphoinositide Dependent Protein Kinase 1 Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 65. Spain 3 Phosphoinositide Dependent Protein Kinase 1 Sales Value Share by Type, 2025 VS 2032 & (%) Figure 66. Spain 3 Phosphoinositide Dependent Protein Kinase 1 Sales Value Share by Application, 2025 VS 2032 & (%) Figure 67. Russia 3 Phosphoinositide Dependent Protein Kinase 1 Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 68. Russia 3 Phosphoinositide Dependent Protein Kinase 1 Sales Value Share by Type, 2025 VS 2032 & (%) Figure 69. Russia 3 Phosphoinositide Dependent Protein Kinase 1 Sales Value Share by Application, 2025 VS 2032 & (%) Figure 70. Netherlands 3 Phosphoinositide Dependent Protein Kinase 1 Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 71. Netherlands 3 Phosphoinositide Dependent Protein Kinase 1 Sales Value Share by Type, 2025 VS 2032 & (%) Figure 72. Netherlands 3 Phosphoinositide Dependent Protein Kinase 1 Sales Value Share by Application, 2025 VS 2032 & (%) Figure 73. Nordic Countries 3 Phosphoinositide Dependent Protein Kinase 1 Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 74. Nordic Countries 3 Phosphoinositide Dependent Protein Kinase 1 Sales Value Share by Type, 2025 VS 2032 & (%) Figure 75. Nordic Countries 3 Phosphoinositide Dependent Protein Kinase 1 Sales Value Share by Application, 2025 VS 2032 & (%) Figure 76. China 3 Phosphoinositide Dependent Protein Kinase 1 Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 77. China 3 Phosphoinositide Dependent Protein Kinase 1 Sales Value Share by Type, 2025 VS 2032 & (%) Figure 78. China 3 Phosphoinositide Dependent Protein Kinase 1 Sales Value Share by Application, 2025 VS 2032 & (%) Figure 79. Japan 3 Phosphoinositide Dependent Protein Kinase 1 Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 80. Japan 3 Phosphoinositide Dependent Protein Kinase 1 Sales Value Share by Type, 2025 VS 2032 & (%) Figure 81. Japan 3 Phosphoinositide Dependent Protein Kinase 1 Sales Value Share by Application, 2025 VS 2032 & (%) Figure 82. South Korea 3 Phosphoinositide Dependent Protein Kinase 1 Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 83. South Korea 3 Phosphoinositide Dependent Protein Kinase 1 Sales Value Share by Type, 2025 VS 2032 & (%) Figure 84. South Korea 3 Phosphoinositide Dependent Protein Kinase 1 Sales Value Share by Application, 2025 VS 2032 & (%) Figure 85. India 3 Phosphoinositide Dependent Protein Kinase 1 Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 86. India 3 Phosphoinositide Dependent Protein Kinase 1 Sales Value Share by Type, 2025 VS 2032 & (%) Figure 87. India 3 Phosphoinositide Dependent Protein Kinase 1 Sales Value Share by Application, 2025 VS 2032 & (%) Figure 88. Australia 3 Phosphoinositide Dependent Protein Kinase 1 Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 89. Australia 3 Phosphoinositide Dependent Protein Kinase 1 Sales Value Share by Type, 2025 VS 2032 & (%) Figure 90. Australia 3 Phosphoinositide Dependent Protein Kinase 1 Sales Value Share by Application, 2025 VS 2032 & (%) Figure 91. Southeast Asia 3 Phosphoinositide Dependent Protein Kinase 1 Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 92. Southeast Asia 3 Phosphoinositide Dependent Protein Kinase 1 Sales Value Share by Type, 2025 VS 2032 & (%) Figure 93. Southeast Asia 3 Phosphoinositide Dependent Protein Kinase 1 Sales Value Share by Application, 2025 VS 2032 & (%) Figure 94. Brazil 3 Phosphoinositide Dependent Protein Kinase 1 Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 95. Brazil 3 Phosphoinositide Dependent Protein Kinase 1 Sales Value Share by Type, 2025 VS 2032 & (%) Figure 96. Brazil 3 Phosphoinositide Dependent Protein Kinase 1 Sales Value Share by Application, 2025 VS 2032 & (%) Figure 97. Argentina 3 Phosphoinositide Dependent Protein Kinase 1 Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 98. Argentina 3 Phosphoinositide Dependent Protein Kinase 1 Sales Value Share by Type, 2025 VS 2032 & (%) Figure 99. Argentina 3 Phosphoinositide Dependent Protein Kinase 1 Sales Value Share by Application, 2025 VS 2032 & (%) Figure 100. Chile 3 Phosphoinositide Dependent Protein Kinase 1 Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 101. Chile 3 Phosphoinositide Dependent Protein Kinase 1 Sales Value Share by Type, 2025 VS 2032 & (%) Figure 102. Chile 3 Phosphoinositide Dependent Protein Kinase 1 Sales Value Share by Application, 2025 VS 2032 & (%) Figure 103. Colombia 3 Phosphoinositide Dependent Protein Kinase 1 Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 104. Colombia 3 Phosphoinositide Dependent Protein Kinase 1 Sales Value Share by Type, 2025 VS 2032 & (%) Figure 105. Colombia 3 Phosphoinositide Dependent Protein Kinase 1 Sales Value Share by Application, 2025 VS 2032 & (%) Figure 106. Peru 3 Phosphoinositide Dependent Protein Kinase 1 Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 107. Peru 3 Phosphoinositide Dependent Protein Kinase 1 Sales Value Share by Type, 2025 VS 2032 & (%) Figure 108. Peru 3 Phosphoinositide Dependent Protein Kinase 1 Sales Value Share by Application, 2025 VS 2032 & (%) Figure 109. Saudi Arabia 3 Phosphoinositide Dependent Protein Kinase 1 Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 110. Saudi Arabia 3 Phosphoinositide Dependent Protein Kinase 1 Sales Value Share by Type, 2025 VS 2032 & (%) Figure 111. Saudi Arabia 3 Phosphoinositide Dependent Protein Kinase 1 Sales Value Share by Application, 2025 VS 2032 & (%) Figure 112. Israel 3 Phosphoinositide Dependent Protein Kinase 1 Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 113. Israel Arabia 3 Phosphoinositide Dependent Protein Kinase 1 Sales Value Share by Type, 2025 VS 2032 & (%) Figure 114. Israel Arabia 3 Phosphoinositide Dependent Protein Kinase 1 Sales Value Share by Application, 2025 VS 2032 & (%) Figure 115. UAE 3 Phosphoinositide Dependent Protein Kinase 1 Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 116. UAE 3 Phosphoinositide Dependent Protein Kinase 1 Sales Value Share by Type, 2025 VS 2032 & (%) Figure 117. UAE 3 Phosphoinositide Dependent Protein Kinase 1 Sales Value Share by Application, 2025 VS 2032 & (%) Figure 118. Turkey 3 Phosphoinositide Dependent Protein Kinase 1 Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 119. Turkey 3 Phosphoinositide Dependent Protein Kinase 1 Sales Value Share by Type, 2025 VS 2032 & (%) Figure 120. Turkey 3 Phosphoinositide Dependent Protein Kinase 1 Sales Value Share by Application, 2025 VS 2032 & (%) Figure 121. Iran 3 Phosphoinositide Dependent Protein Kinase 1 Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 122. Iran 3 Phosphoinositide Dependent Protein Kinase 1 Sales Value Share by Type, 2025 VS 2032 & (%) Figure 123. Iran 3 Phosphoinositide Dependent Protein Kinase 1 Sales Value Share by Application, 2025 VS 2032 & (%) Figure 124. Egypt 3 Phosphoinositide Dependent Protein Kinase 1 Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 125. Egypt 3 Phosphoinositide Dependent Protein Kinase 1 Sales Value Share by Type, 2025 VS 2032 & (%) Figure 126. Egypt 3 Phosphoinositide Dependent Protein Kinase 1 Sales Value Share by Application, 2025 VS 2032 & (%) Figure 127. 3 Phosphoinositide Dependent Protein Kinase 1 Value Chain Figure 128. Manufacturing Cost Structure Figure 129. 3 Phosphoinositide Dependent Protein Kinase 1 Sales Mode & Process Figure 130. Direct Comparison with Distribution Share Figure 131. Distributors Profiles Figure 132. Years Considered Figure 133. Research Process Figure 134. Key Executives Interviewed

Scope & coverage.

Types
  • SNS-229
  • PHT-427
  • HCI-1708
  • AR-12
  • Others
Applications
  • Clinic
  • Hospital
  • Others
Companies covered
  • Tolero Pharmaceuticals, Inc.
  • Sunesis Pharmaceuticals, Inc.
  • Arno Therapeutics, Inc.

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Market Growth Prospects
  3. 1.2.1 Global 3 Phosphoinositide Dependent Protein Kinase 1 Sales Value (2021-2032)
  4. 1.2.2 Global 3 Phosphoinositide Dependent Protein Kinase 1 Sales Volume (2021-2032)
  5. 1.2.3 Global 3 Phosphoinositide Dependent Protein Kinase 1 Sales Average Price (2021-2032)
  6. 1.3 Assumptions and Limitations
  7. 1.4 Study Goals and Objectives
2 3 Phosphoinositide Dependent Protein Kinase 1 Market Dynamics
  1. 2.1 3 Phosphoinositide Dependent Protein Kinase 1 Industry Trends
  2. 2.2 3 Phosphoinositide Dependent Protein Kinase 1 Industry Drivers
  3. 2.3 3 Phosphoinositide Dependent Protein Kinase 1 Industry Opportunities and Challenges
  4. 2.4 3 Phosphoinositide Dependent Protein Kinase 1 Industry Restraints
3 3 Phosphoinositide Dependent Protein Kinase 1 Market by Company
  1. 3.1 Global 3 Phosphoinositide Dependent Protein Kinase 1 Company Revenue Ranking in 2025
  2. 3.2 Global 3 Phosphoinositide Dependent Protein Kinase 1 Revenue by Company (2021-2026)
  3. 3.3 Global 3 Phosphoinositide Dependent Protein Kinase 1 Sales Volume by Company (2021-2026)
  4. 3.4 Global 3 Phosphoinositide Dependent Protein Kinase 1 Average Price by Company (2021-2026)
  5. 3.5 Global 3 Phosphoinositide Dependent Protein Kinase 1 Company Ranking (2024-2026)
  6. 3.6 Global 3 Phosphoinositide Dependent Protein Kinase 1 Company Manufacturing Base and Headquarters
  7. 3.7 Global 3 Phosphoinositide Dependent Protein Kinase 1 Company Product Type and Application
  8. 3.8 Global 3 Phosphoinositide Dependent Protein Kinase 1 Company Establishment Date
  9. 3.9 Market Competitive Analysis
  10. 3.9.1 Global 3 Phosphoinositide Dependent Protein Kinase 1 Market Concentration Ratio (CR5 and HHI)
  11. 3.9.2 Global Top 5 and 10 Company Market Share by Revenue in 2025
  12. 3.9.3 2025 3 Phosphoinositide Dependent Protein Kinase 1 Tier 1, Tier 2, and Tier 3 Companies
  13. 3.10 Mergers and Acquisitions Expansion
4 3 Phosphoinositide Dependent Protein Kinase 1 Market by Type
  1. 4.1 3 Phosphoinositide Dependent Protein Kinase 1 Type Introduction
  2. 4.1.1 SNS-229
  3. 4.1.2 PHT-427
  4. 4.1.3 HCI-1708
  5. 4.1.4 AR-12
  6. 4.1.5 Others
  7. 4.2 Global 3 Phosphoinositide Dependent Protein Kinase 1 Sales Volume by Type
  8. 4.2.1 Global 3 Phosphoinositide Dependent Protein Kinase 1 Sales Volume by Type (2021 VS 2025 VS 2032)
  9. 4.2.2 Global 3 Phosphoinositide Dependent Protein Kinase 1 Sales Volume by Type (2021-2032)
  10. 4.2.3 Global 3 Phosphoinositide Dependent Protein Kinase 1 Sales Volume Share by Type (2021-2032)
  11. 4.3 Global 3 Phosphoinositide Dependent Protein Kinase 1 Sales Value by Type
  12. 4.3.1 Global 3 Phosphoinositide Dependent Protein Kinase 1 Sales Value by Type (2021 VS 2025 VS 2032)
  13. 4.3.2 Global 3 Phosphoinositide Dependent Protein Kinase 1 Sales Value by Type (2021-2032)
  14. 4.3.3 Global 3 Phosphoinositide Dependent Protein Kinase 1 Sales Value Share by Type (2021-2032)
5 3 Phosphoinositide Dependent Protein Kinase 1 Market by Application
  1. 5.1 3 Phosphoinositide Dependent Protein Kinase 1 Application Introduction
  2. 5.1.1 Clinic
  3. 5.1.2 Hospital
  4. 5.1.3 Others
  5. 5.2 Global 3 Phosphoinositide Dependent Protein Kinase 1 Sales Volume by Application
  6. 5.2.1 Global 3 Phosphoinositide Dependent Protein Kinase 1 Sales Volume by Application (2021 VS 2025 VS 2032)
  7. 5.2.2 Global 3 Phosphoinositide Dependent Protein Kinase 1 Sales Volume by Application (2021-2032)
  8. 5.2.3 Global 3 Phosphoinositide Dependent Protein Kinase 1 Sales Volume Share by Application (2021-2032)
  9. 5.3 Global 3 Phosphoinositide Dependent Protein Kinase 1 Sales Value by Application
  10. 5.3.1 Global 3 Phosphoinositide Dependent Protein Kinase 1 Sales Value by Application (2021 VS 2025 VS 2032)
  11. 5.3.2 Global 3 Phosphoinositide Dependent Protein Kinase 1 Sales Value by Application (2021-2032)
  12. 5.3.3 Global 3 Phosphoinositide Dependent Protein Kinase 1 Sales Value Share by Application (2021-2032)
6 3 Phosphoinositide Dependent Protein Kinase 1 Regional Sales and Value Analysis
  1. 6.1 Global 3 Phosphoinositide Dependent Protein Kinase 1 Sales by Region: 2021 VS 2025 VS 2032
  2. 6.2 Global 3 Phosphoinositide Dependent Protein Kinase 1 Sales by Region (2021-2032)
  3. 6.2.1 Global 3 Phosphoinositide Dependent Protein Kinase 1 Sales by Region: 2021-2026
  4. 6.2.2 Global 3 Phosphoinositide Dependent Protein Kinase 1 Sales by Region (2027-2032)
  5. 6.3 Global 3 Phosphoinositide Dependent Protein Kinase 1 Sales Value by Region: 2021 VS 2025 VS 2032
  6. 6.4 Global 3 Phosphoinositide Dependent Protein Kinase 1 Sales Value by Region (2021-2032)
  7. 6.4.1 Global 3 Phosphoinositide Dependent Protein Kinase 1 Sales Value by Region: 2021-2026
  8. 6.4.2 Global 3 Phosphoinositide Dependent Protein Kinase 1 Sales Value by Region (2027-2032)
  9. 6.5 Global 3 Phosphoinositide Dependent Protein Kinase 1 Market Price Analysis by Region (2021-2026)
  10. 6.6 North America
  11. 6.6.1 North America 3 Phosphoinositide Dependent Protein Kinase 1 Sales Value (2021-2032)
  12. 6.6.2 North America 3 Phosphoinositide Dependent Protein Kinase 1 Sales Value Share by Country, 2025 VS 2032
  13. 6.7 Europe
  14. 6.7.1 Europe 3 Phosphoinositide Dependent Protein Kinase 1 Sales Value (2021-2032)
  15. 6.7.2 Europe 3 Phosphoinositide Dependent Protein Kinase 1 Sales Value Share by Country, 2025 VS 2032
  16. 6.8 Asia-Pacific
  17. 6.8.1 Asia-Pacific 3 Phosphoinositide Dependent Protein Kinase 1 Sales Value (2021-2032)
  18. 6.8.2 Asia-Pacific 3 Phosphoinositide Dependent Protein Kinase 1 Sales Value Share by Country, 2025 VS 2032
  19. 6.9 South America
  20. 6.9.1 South America 3 Phosphoinositide Dependent Protein Kinase 1 Sales Value (2021-2032)
  21. 6.9.2 South America 3 Phosphoinositide Dependent Protein Kinase 1 Sales Value Share by Country, 2025 VS 2032
  22. 6.10 Middle East & Africa
  23. 6.10.1 Middle East & Africa 3 Phosphoinositide Dependent Protein Kinase 1 Sales Value (2021-2032)
  24. 6.10.2 Middle East & Africa 3 Phosphoinositide Dependent Protein Kinase 1 Sales Value Share by Country, 2025 VS 2032
7 3 Phosphoinositide Dependent Protein Kinase 1 Country-level Sales and Value Analysis
  1. 7.1 Global 3 Phosphoinositide Dependent Protein Kinase 1 Sales by Country: 2021 VS 2025 VS 2032
  2. 7.2 Global 3 Phosphoinositide Dependent Protein Kinase 1 Sales Value by Country: 2021 VS 2025 VS 2032
  3. 7.3 Global 3 Phosphoinositide Dependent Protein Kinase 1 Sales by Country (2021-2032)
  4. 7.3.1 Global 3 Phosphoinositide Dependent Protein Kinase 1 Sales by Country (2021-2026)
  5. 7.3.2 Global 3 Phosphoinositide Dependent Protein Kinase 1 Sales by Country (2027-2032)
  6. 7.4 Global 3 Phosphoinositide Dependent Protein Kinase 1 Sales Value by Country (2021-2032)
  7. 7.4.1 Global 3 Phosphoinositide Dependent Protein Kinase 1 Sales Value by Country (2021-2026)
  8. 7.4.2 Global 3 Phosphoinositide Dependent Protein Kinase 1 Sales Value by Country (2027-2032)
  9. 7.5 USA
  10. 7.5.1 USA 3 Phosphoinositide Dependent Protein Kinase 1 Sales Value Growth Rate (2021-2032)
  11. 7.5.2 USA 3 Phosphoinositide Dependent Protein Kinase 1 Sales Value Share by Type, 2025 VS 2032
  12. 7.5.3 USA 3 Phosphoinositide Dependent Protein Kinase 1 Sales Value Share by Application, 2025 VS 2032
  13. 7.6 Canada
  14. 7.6.1 Canada 3 Phosphoinositide Dependent Protein Kinase 1 Sales Value Growth Rate (2021-2032)
  15. 7.6.2 Canada 3 Phosphoinositide Dependent Protein Kinase 1 Sales Value Share by Type, 2025 VS 2032
  16. 7.6.3 Canada 3 Phosphoinositide Dependent Protein Kinase 1 Sales Value Share by Application, 2025 VS 2032
  17. 7.7 Mexico
  18. 7.6.1 Mexico 3 Phosphoinositide Dependent Protein Kinase 1 Sales Value Growth Rate (2021-2032)
  19. 7.6.2 Mexico 3 Phosphoinositide Dependent Protein Kinase 1 Sales Value Share by Type, 2025 VS 2032
  20. 7.6.3 Mexico 3 Phosphoinositide Dependent Protein Kinase 1 Sales Value Share by Application, 2025 VS 2032
  21. 7.8 Germany
  22. 7.8.1 Germany 3 Phosphoinositide Dependent Protein Kinase 1 Sales Value Growth Rate (2021-2032)
  23. 7.8.2 Germany 3 Phosphoinositide Dependent Protein Kinase 1 Sales Value Share by Type, 2025 VS 2032
  24. 7.8.3 Germany 3 Phosphoinositide Dependent Protein Kinase 1 Sales Value Share by Application, 2025 VS 2032
  25. 7.9 France
  26. 7.9.1 France 3 Phosphoinositide Dependent Protein Kinase 1 Sales Value Growth Rate (2021-2032)
  27. 7.9.2 France 3 Phosphoinositide Dependent Protein Kinase 1 Sales Value Share by Type, 2025 VS 2032
  28. 7.9.3 France 3 Phosphoinositide Dependent Protein Kinase 1 Sales Value Share by Application, 2025 VS 2032
  29. 7.10 U.K.
  30. 7.10.1 U.K. 3 Phosphoinositide Dependent Protein Kinase 1 Sales Value Growth Rate (2021-2032)
  31. 7.10.2 U.K. 3 Phosphoinositide Dependent Protein Kinase 1 Sales Value Share by Type, 2025 VS 2032
  32. 7.10.3 U.K. 3 Phosphoinositide Dependent Protein Kinase 1 Sales Value Share by Application, 2025 VS 2032
  33. 7.11 Italy
  34. 7.11.1 Italy 3 Phosphoinositide Dependent Protein Kinase 1 Sales Value Growth Rate (2021-2032)
  35. 7.11.2 Italy 3 Phosphoinositide Dependent Protein Kinase 1 Sales Value Share by Type, 2025 VS 2032
  36. 7.11.3 Italy 3 Phosphoinositide Dependent Protein Kinase 1 Sales Value Share by Application, 2025 VS 2032
  37. 7.12 Spain
  38. 7.12.1 Spain 3 Phosphoinositide Dependent Protein Kinase 1 Sales Value Growth Rate (2021-2032)
  39. 7.12.2 Spain 3 Phosphoinositide Dependent Protein Kinase 1 Sales Value Share by Type, 2025 VS 2032
  40. 7.12.3 Spain 3 Phosphoinositide Dependent Protein Kinase 1 Sales Value Share by Application, 2025 VS 2032
  41. 7.13 Russia
  42. 7.13.1 Russia 3 Phosphoinositide Dependent Protein Kinase 1 Sales Value Growth Rate (2021-2032)
  43. 7.13.2 Russia 3 Phosphoinositide Dependent Protein Kinase 1 Sales Value Share by Type, 2025 VS 2032
  44. 7.13.3 Russia 3 Phosphoinositide Dependent Protein Kinase 1 Sales Value Share by Application, 2025 VS 2032
  45. 7.14 Netherlands
  46. 7.14.1 Netherlands 3 Phosphoinositide Dependent Protein Kinase 1 Sales Value Growth Rate (2021-2032)
  47. 7.14.2 Netherlands 3 Phosphoinositide Dependent Protein Kinase 1 Sales Value Share by Type, 2025 VS 2032
  48. 7.14.3 Netherlands 3 Phosphoinositide Dependent Protein Kinase 1 Sales Value Share by Application, 2025 VS 2032
  49. 7.15 Nordic Countries
  50. 7.15.1 Nordic Countries 3 Phosphoinositide Dependent Protein Kinase 1 Sales Value Growth Rate (2021-2032)
  51. 7.15.2 Nordic Countries 3 Phosphoinositide Dependent Protein Kinase 1 Sales Value Share by Type, 2025 VS 2032
  52. 7.15.3 Nordic Countries 3 Phosphoinositide Dependent Protein Kinase 1 Sales Value Share by Application, 2025 VS 2032
  53. 7.16 China
  54. 7.16.1 China 3 Phosphoinositide Dependent Protein Kinase 1 Sales Value Growth Rate (2021-2032)
  55. 7.16.2 China 3 Phosphoinositide Dependent Protein Kinase 1 Sales Value Share by Type, 2025 VS 2032
  56. 7.16.3 China 3 Phosphoinositide Dependent Protein Kinase 1 Sales Value Share by Application, 2025 VS 2032
  57. 7.17 Japan
  58. 7.17.1 Japan 3 Phosphoinositide Dependent Protein Kinase 1 Sales Value Growth Rate (2021-2032)
  59. 7.17.2 Japan 3 Phosphoinositide Dependent Protein Kinase 1 Sales Value Share by Type, 2025 VS 2032
  60. 7.17.3 Japan 3 Phosphoinositide Dependent Protein Kinase 1 Sales Value Share by Application, 2025 VS 2032
  61. 7.18 South Korea
  62. 7.18.1 South Korea 3 Phosphoinositide Dependent Protein Kinase 1 Sales Value Growth Rate (2021-2032)
  63. 7.18.2 South Korea 3 Phosphoinositide Dependent Protein Kinase 1 Sales Value Share by Type, 2025 VS 2032
  64. 7.18.3 South Korea 3 Phosphoinositide Dependent Protein Kinase 1 Sales Value Share by Application, 2025 VS 2032
  65. 7.19 India
  66. 7.19.1 India 3 Phosphoinositide Dependent Protein Kinase 1 Sales Value Growth Rate (2021-2032)
  67. 7.19.2 India 3 Phosphoinositide Dependent Protein Kinase 1 Sales Value Share by Type, 2025 VS 2032
  68. 7.19.3 India 3 Phosphoinositide Dependent Protein Kinase 1 Sales Value Share by Application, 2025 VS 2032
  69. 7.20 Australia
  70. 7.20.1 Australia 3 Phosphoinositide Dependent Protein Kinase 1 Sales Value Growth Rate (2021-2032)
  71. 7.20.2 Australia 3 Phosphoinositide Dependent Protein Kinase 1 Sales Value Share by Type, 2025 VS 2032
  72. 7.20.3 Australia 3 Phosphoinositide Dependent Protein Kinase 1 Sales Value Share by Application, 2025 VS 2032
  73. 7.21 Southeast Asia
  74. 7.21.1 Southeast Asia 3 Phosphoinositide Dependent Protein Kinase 1 Sales Value Growth Rate (2021-2032)
  75. 7.21.2 Southeast Asia 3 Phosphoinositide Dependent Protein Kinase 1 Sales Value Share by Type, 2025 VS 2032
  76. 7.21.3 Southeast Asia 3 Phosphoinositide Dependent Protein Kinase 1 Sales Value Share by Application, 2025 VS 2032
  77. 7.22 Brazil
  78. 7.22.1 Brazil 3 Phosphoinositide Dependent Protein Kinase 1 Sales Value Growth Rate (2021-2032)
  79. 7.22.2 Brazil 3 Phosphoinositide Dependent Protein Kinase 1 Sales Value Share by Type, 2025 VS 2032
  80. 7.22.3 Brazil 3 Phosphoinositide Dependent Protein Kinase 1 Sales Value Share by Application, 2025 VS 2032
  81. 7.23 Argentina
  82. 7.23.1 Argentina 3 Phosphoinositide Dependent Protein Kinase 1 Sales Value Growth Rate (2021-2032)
  83. 7.23.2 Argentina 3 Phosphoinositide Dependent Protein Kinase 1 Sales Value Share by Type, 2025 VS 2032
  84. 7.23.3 Argentina 3 Phosphoinositide Dependent Protein Kinase 1 Sales Value Share by Application, 2025 VS 2032
  85. 7.24 Chile
  86. 7.24.1 Chile 3 Phosphoinositide Dependent Protein Kinase 1 Sales Value Growth Rate (2021-2032)
  87. 7.24.2 Chile 3 Phosphoinositide Dependent Protein Kinase 1 Sales Value Share by Type, 2025 VS 2032
  88. 7.24.3 Chile 3 Phosphoinositide Dependent Protein Kinase 1 Sales Value Share by Application, 2025 VS 2032
  89. 7.25 Colombia
  90. 7.25.1 Colombia 3 Phosphoinositide Dependent Protein Kinase 1 Sales Value Growth Rate (2021-2032)
  91. 7.25.2 Colombia 3 Phosphoinositide Dependent Protein Kinase 1 Sales Value Share by Type, 2025 VS 2032
  92. 7.25.3 Colombia 3 Phosphoinositide Dependent Protein Kinase 1 Sales Value Share by Application, 2025 VS 2032
  93. 7.26 Peru
  94. 7.26.1 Peru 3 Phosphoinositide Dependent Protein Kinase 1 Sales Value Growth Rate (2021-2032)
  95. 7.26.2 Peru 3 Phosphoinositide Dependent Protein Kinase 1 Sales Value Share by Type, 2025 VS 2032
  96. 7.26.3 Peru 3 Phosphoinositide Dependent Protein Kinase 1 Sales Value Share by Application, 2025 VS 2032
  97. 7.27 Saudi Arabia
  98. 7.27.1 Saudi Arabia 3 Phosphoinositide Dependent Protein Kinase 1 Sales Value Growth Rate (2021-2032)
  99. 7.27.2 Saudi Arabia 3 Phosphoinositide Dependent Protein Kinase 1 Sales Value Share by Type, 2025 VS 2032
  100. 7.27.3 Saudi Arabia 3 Phosphoinositide Dependent Protein Kinase 1 Sales Value Share by Application, 2025 VS 2032
  101. 7.28 Israel
  102. 7.28.1 Israel 3 Phosphoinositide Dependent Protein Kinase 1 Sales Value Growth Rate (2021-2032)
  103. 7.28.2 Israel 3 Phosphoinositide Dependent Protein Kinase 1 Sales Value Share by Type, 2025 VS 2032
  104. 7.28.3 Israel 3 Phosphoinositide Dependent Protein Kinase 1 Sales Value Share by Application, 2025 VS 2032
  105. 7.29 UAE
  106. 7.29.1 UAE 3 Phosphoinositide Dependent Protein Kinase 1 Sales Value Growth Rate (2021-2032)
  107. 7.29.2 UAE 3 Phosphoinositide Dependent Protein Kinase 1 Sales Value Share by Type, 2025 VS 2032
  108. 7.29.3 UAE 3 Phosphoinositide Dependent Protein Kinase 1 Sales Value Share by Application, 2025 VS 2032
  109. 7.30 Turkey
  110. 7.30.1 Turkey 3 Phosphoinositide Dependent Protein Kinase 1 Sales Value Growth Rate (2021-2032)
  111. 7.30.2 Turkey 3 Phosphoinositide Dependent Protein Kinase 1 Sales Value Share by Type, 2025 VS 2032
  112. 7.30.3 Turkey 3 Phosphoinositide Dependent Protein Kinase 1 Sales Value Share by Application, 2025 VS 2032
  113. 7.31 Iran
  114. 7.31.1 Iran 3 Phosphoinositide Dependent Protein Kinase 1 Sales Value Growth Rate (2021-2032)
  115. 7.31.2 Iran 3 Phosphoinositide Dependent Protein Kinase 1 Sales Value Share by Type, 2025 VS 2032
  116. 7.31.3 Iran 3 Phosphoinositide Dependent Protein Kinase 1 Sales Value Share by Application, 2025 VS 2032
  117. 7.32 Egypt
  118. 7.32.1 Egypt 3 Phosphoinositide Dependent Protein Kinase 1 Sales Value Growth Rate (2021-2032)
  119. 7.32.2 Egypt 3 Phosphoinositide Dependent Protein Kinase 1 Sales Value Share by Type, 2025 VS 2032
  120. 7.32.3 Egypt 3 Phosphoinositide Dependent Protein Kinase 1 Sales Value Share by Application, 2025 VS 2032
8 Company Profiles
  1. 8.1 Tolero Pharmaceuticals, Inc.
  2. 8.1.1 Tolero Pharmaceuticals, Inc. Company Information
  3. 8.1.2 Tolero Pharmaceuticals, Inc. Business Overview
  4. 8.1.3 Tolero Pharmaceuticals, Inc. 3 Phosphoinositide Dependent Protein Kinase 1 Sales, Value and Gross Margin (2021-2026)
  5. 8.1.4 Tolero Pharmaceuticals, Inc. 3 Phosphoinositide Dependent Protein Kinase 1 Product Portfolio
  6. 8.1.5 Tolero Pharmaceuticals, Inc. Recent Developments
  7. 8.2 Sunesis Pharmaceuticals, Inc.
  8. 8.2.1 Sunesis Pharmaceuticals, Inc. Company Information
  9. 8.2.2 Sunesis Pharmaceuticals, Inc. Business Overview
  10. 8.2.3 Sunesis Pharmaceuticals, Inc. 3 Phosphoinositide Dependent Protein Kinase 1 Sales, Value and Gross Margin (2021-2026)
  11. 8.2.4 Sunesis Pharmaceuticals, Inc. 3 Phosphoinositide Dependent Protein Kinase 1 Product Portfolio
  12. 8.2.5 Sunesis Pharmaceuticals, Inc. Recent Developments
  13. 8.3 Arno Therapeutics, Inc.
  14. 8.3.1 Arno Therapeutics, Inc. Company Information
  15. 8.3.2 Arno Therapeutics, Inc. Business Overview
  16. 8.3.3 Arno Therapeutics, Inc. 3 Phosphoinositide Dependent Protein Kinase 1 Sales, Value and Gross Margin (2021-2026)
  17. 8.3.4 Arno Therapeutics, Inc. 3 Phosphoinositide Dependent Protein Kinase 1 Product Portfolio
  18. 8.3.5 Arno Therapeutics, Inc. Recent Developments
9 Value Chain and Sales Channels Analysis
  1. 9.1 3 Phosphoinositide Dependent Protein Kinase 1 Value Chain Analysis
  2. 9.1.1 3 Phosphoinositide Dependent Protein Kinase 1 Key Raw Materials
  3. 9.1.2 Raw Materials Key Suppliers
  4. 9.1.3 Manufacturing Cost Structure
  5. 9.1.4 3 Phosphoinositide Dependent Protein Kinase 1 Sales Mode & Process
  6. 9.2 3 Phosphoinositide Dependent Protein Kinase 1 Sales Channels Analysis
  7. 9.2.1 Direct Comparison with Distribution Share
  8. 9.2.2 3 Phosphoinositide Dependent Protein Kinase 1 Distributors
  9. 9.2.3 3 Phosphoinositide Dependent Protein Kinase 1 Customers
10 Concluding Insights
    11 Appendix
    1. 11.1 Reasons for Doing This Study
    2. 11.2 Research Methodology
    3. 11.3 Research Process
    4. 11.4 Authors List of This Report
    5. 11.5 Data Source
    6. 11.5.1 Secondary Sources
    7. 11.5.2 Primary Sources

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $4,250USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst